| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | increased circulating LDL cholesterol level | 3.50e-07 | 80 | 80 | 7 | MP:0000182 | |
| MousePheno | increased circulating HDL cholesterol level | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 ANKRD11 YDJC | 8.38e-06 | 238 | 80 | 9 | MP:0001556 |
| MousePheno | abnormal circulating LDL cholesterol level | 4.01e-05 | 163 | 80 | 7 | MP:0000181 | |
| MousePheno | increased circulating cholesterol level | GPD2 RALGAPA1 CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 ANKRD11 YDJC | 6.22e-05 | 463 | 80 | 11 | MP:0005178 |
| MousePheno | abnormal circulating non-HDL cholesterol level | 7.52e-05 | 180 | 80 | 7 | MP:0020151 | |
| MousePheno | increased cholesterol level | GPD2 RALGAPA1 CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 ANKRD11 YDJC | 1.28e-04 | 502 | 80 | 11 | MP:0003982 |
| MousePheno | increased sterol level | GPD2 RALGAPA1 CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A3 ANKRD11 YDJC | 1.35e-04 | 505 | 80 | 11 | MP:0012226 |
| Domain | NPIP | NPIPB15 NPIPB9 NPIPA1 NPIPB3 NPIPB5 NPIPA7 NPIPB2 NPIPB8 NPIPB13 NPIPB6 NPIPA5 NPIPA3 | 4.69e-26 | 14 | 105 | 12 | IPR009443 |
| Domain | INT_SG_DDX_CT_C | 2.82e-10 | 8 | 105 | 5 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 2.82e-10 | 8 | 105 | 5 | IPR029307 | |
| Domain | RmlC_Cupin | 9.17e-05 | 16 | 105 | 3 | IPR011051 | |
| Domain | TACC | 9.36e-05 | 3 | 105 | 2 | PF05010 | |
| Domain | TACC | 9.36e-05 | 3 | 105 | 2 | IPR007707 | |
| Domain | SPHK1-interactor_AKAP_110 | 1.86e-04 | 4 | 105 | 2 | IPR008382 | |
| Domain | AKAP_110 | 1.86e-04 | 4 | 105 | 2 | PF05716 | |
| Domain | PDZ | 1.20e-03 | 141 | 105 | 5 | PF00595 | |
| Domain | Ank_2 | 1.36e-03 | 215 | 105 | 6 | PF12796 | |
| Domain | Rap_GAP | 1.37e-03 | 10 | 105 | 2 | PF02145 | |
| Domain | PDZ | 1.49e-03 | 148 | 105 | 5 | SM00228 | |
| Domain | - | 1.58e-03 | 150 | 105 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.63e-03 | 151 | 105 | 5 | PS50106 | |
| Domain | Rap_GAP_dom | 1.67e-03 | 11 | 105 | 2 | IPR000331 | |
| Domain | RAPGAP | 1.67e-03 | 11 | 105 | 2 | PS50085 | |
| Domain | PDZ | 1.68e-03 | 152 | 105 | 5 | IPR001478 | |
| Domain | Ank | 1.83e-03 | 228 | 105 | 6 | PF00023 | |
| Domain | L27 | 2.35e-03 | 13 | 105 | 2 | SM00569 | |
| Domain | L27 | 2.35e-03 | 13 | 105 | 2 | PS51022 | |
| Domain | L27_dom | 2.35e-03 | 13 | 105 | 2 | IPR004172 | |
| Domain | - | 2.78e-03 | 248 | 105 | 6 | 1.25.40.20 | |
| Domain | ANK | 2.95e-03 | 251 | 105 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 3.07e-03 | 253 | 105 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 3.13e-03 | 254 | 105 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.13e-03 | 254 | 105 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 3.64e-03 | 262 | 105 | 6 | IPR002110 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 2.71e-19 | 15 | 121 | 9 | 15905330 |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 1.64e-07 | 4 | 121 | 3 | 18055785 | |
| Pubmed | MRC1 CT45A6 CT45A1 CT45A10 CT45A2 GABBR2 CT45A7 CT45A9 KMT2D CT45A3 NYNRIN ZFHX2 IL6R | 7.01e-07 | 674 | 121 | 13 | 37196079 | |
| Pubmed | 7.97e-07 | 21 | 121 | 4 | 16079250 | ||
| Pubmed | 1.69e-06 | 233 | 121 | 8 | 37704626 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 1.15e-05 | 13 | 121 | 3 | 17920017 | |
| Pubmed | PPM1D activity promotes the replication stress caused by cyclin E1 overexpression. | 1.20e-05 | 2 | 121 | 2 | 37067201 | |
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 1.20e-05 | 2 | 121 | 2 | 11586358 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10435627 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 9192623 | ||
| Pubmed | The sequence and analysis of duplication-rich human chromosome 16. | 1.63e-05 | 90 | 121 | 5 | 15616553 | |
| Pubmed | The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. | 3.59e-05 | 3 | 121 | 2 | 11121038 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22994563 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15226440 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 3.59e-05 | 3 | 121 | 2 | 11948212 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25429137 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25679765 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 RALGAPA1 RAP1GAP CARMIL1 MPDZ KIAA1671 PTPN3 DLC1 PLEKHA3 ANKRD11 AKAP11 AHNAK2 | 4.88e-05 | 861 | 121 | 12 | 36931259 |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 25977097 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 15207008 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 10366448 | ||
| Pubmed | NCOA2 TANC2 TRAPPC11 RAD51AP2 KMT2D NFKBIB CDK5RAP2 PRRC2B AHNAK2 DNAH11 | 8.21e-05 | 638 | 121 | 10 | 31182584 | |
| Pubmed | Lineage-specific gene duplication and loss in human and great ape evolution. | 1.01e-04 | 69 | 121 | 4 | 15252450 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ANK2 CARMIL1 TACC2 ZNF512B KIAA1671 SUGP2 MASTL TACC1 PRR14L PRRC2B AHNAK2 HDLBP | 1.05e-04 | 934 | 121 | 12 | 33916271 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CT45A6 CT45A1 TTLL3 CT45A10 CARMIL1 CT45A2 GBA2 CT45A7 CT45A9 NACC2 CT45A3 CDK5RAP2 YDJC PRRC2B | 1.10e-04 | 1242 | 121 | 14 | 30973865 |
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 27633981 | ||
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 19925052 | ||
| Pubmed | 1.78e-04 | 6 | 121 | 2 | 33476547 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 RALGAPA1 TTLL3 ZNF875 CARMIL1 SHROOM2 KIAA1671 SUGP2 NACC2 TBCK MKLN1 ANKRD11 ZFHX2 DLG1 IL6R | 2.12e-04 | 1489 | 121 | 15 | 28611215 |
| Pubmed | The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. | 2.49e-04 | 7 | 121 | 2 | 14767476 | |
| Pubmed | Blimp-1 is essential for allergen-induced asthma and Th2 cell development in the lung. | 2.49e-04 | 7 | 121 | 2 | 32399548 | |
| Pubmed | RALGAPA1 CENPE UBXN8 AKAP3 MPDZ POLR3B MASTL DLG1 TACC1 PRR14L | 2.52e-04 | 733 | 121 | 10 | 34672954 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 2.70e-04 | 36 | 121 | 3 | 26053890 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 3.08e-04 | 92 | 121 | 4 | 10493829 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 3.31e-04 | 170 | 121 | 5 | 23314748 | |
| Pubmed | 3.32e-04 | 8 | 121 | 2 | 14602875 | ||
| Pubmed | Anchoring and scaffold proteins for kinases and phosphatases. | 4.25e-04 | 9 | 121 | 2 | 9238861 | |
| Pubmed | 4.25e-04 | 9 | 121 | 2 | 15184363 | ||
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 4.55e-04 | 102 | 121 | 4 | 20508983 | |
| Pubmed | 5.30e-04 | 10 | 121 | 2 | 33941650 | ||
| Pubmed | 5.30e-04 | 10 | 121 | 2 | 11807172 | ||
| Pubmed | Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. | 6.47e-04 | 11 | 121 | 2 | 18082152 | |
| Pubmed | Transient microglial absence assists postmigratory cortical neurons in proper differentiation. | 6.47e-04 | 11 | 121 | 2 | 32242005 | |
| Pubmed | 6.94e-04 | 549 | 121 | 8 | 38280479 | ||
| Pubmed | 7.74e-04 | 12 | 121 | 2 | 27563068 | ||
| Pubmed | 9.13e-04 | 13 | 121 | 2 | 23576434 | ||
| Pubmed | 1.06e-03 | 14 | 121 | 2 | 12482968 | ||
| Pubmed | TGF-β specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf. | 1.06e-03 | 14 | 121 | 2 | 38427718 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 1.06e-03 | 14 | 121 | 2 | 11500849 | |
| Pubmed | κB-Ras proteins regulate both NF-κB-dependent inflammation and Ral-dependent proliferation. | 1.06e-03 | 14 | 121 | 2 | 25220458 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.08e-03 | 588 | 121 | 8 | 38580884 | |
| Pubmed | GPD2 RALGAPA1 PPM1D ZNF512B KIAA1671 PTPN3 KMT2D DLG1 CDK5RAP2 PRRC2B HDLBP | 1.11e-03 | 1049 | 121 | 11 | 27880917 | |
| Pubmed | 1.22e-03 | 15 | 121 | 2 | 20237282 | ||
| Pubmed | 1.22e-03 | 15 | 121 | 2 | 34835087 | ||
| Pubmed | TANC2 GPD2 RALGAPA1 RAP1GAP ANK2 CARMIL1 EIF2S3B SHROOM2 SUGP2 DLG1 PRRC2B DNAH11 HDLBP | 1.46e-03 | 1431 | 121 | 13 | 37142655 | |
| Pubmed | 1.47e-03 | 64 | 121 | 3 | 20332099 | ||
| Pubmed | 1.58e-03 | 17 | 121 | 2 | 2355006 | ||
| Pubmed | 1.58e-03 | 17 | 121 | 2 | 9250876 | ||
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 1.58e-03 | 17 | 121 | 2 | 23502783 | |
| Pubmed | NCOA2 RAP1GAP ANK2 WHAMM SHROOM2 DSCAML1 ZNF512B POLR3B FEZ1 ADAMTS9 MKLN1 DLG1 | 1.78e-03 | 1285 | 121 | 12 | 35914814 | |
| Pubmed | 1.92e-03 | 370 | 121 | 6 | 15164053 | ||
| Pubmed | 1.97e-03 | 19 | 121 | 2 | 24315451 | ||
| Pubmed | 2.19e-03 | 20 | 121 | 2 | 12560567 | ||
| Pubmed | 2.40e-03 | 76 | 121 | 3 | 10574461 | ||
| Pubmed | 2.41e-03 | 21 | 121 | 2 | 21509594 | ||
| Pubmed | 2.52e-03 | 268 | 121 | 5 | 33640491 | ||
| Pubmed | TRAPPC11 PLB1 PPM1D CARD10 ZNF512B KIAA1671 MASTL CREB3L3 AHNAK2 | 2.57e-03 | 832 | 121 | 9 | 36724073 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 2.65e-03 | 22 | 121 | 2 | 26886794 | |
| Pubmed | Negative modulation of androgen receptor transcriptional activity by Daxx. | 2.65e-03 | 22 | 121 | 2 | 15572661 | |
| Pubmed | 2.65e-03 | 22 | 121 | 2 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 2.65e-03 | 22 | 121 | 2 | 9109416 | |
| Pubmed | 2.65e-03 | 22 | 121 | 2 | 11530211 | ||
| Pubmed | 2.90e-03 | 23 | 121 | 2 | 1736542 | ||
| Pubmed | 2.90e-03 | 23 | 121 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 2.90e-03 | 23 | 121 | 2 | 3099781 | |
| Pubmed | Genomic variants in an inbred mouse model predict mania-like behaviors. | 2.90e-03 | 23 | 121 | 2 | 29768498 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 2.90e-03 | 23 | 121 | 2 | 3264072 | |
| Pubmed | 3.15e-03 | 24 | 121 | 2 | 15561968 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.26e-03 | 552 | 121 | 7 | 10737800 | |
| Pubmed | 3.41e-03 | 708 | 121 | 8 | 39231216 | ||
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 3.42e-03 | 25 | 121 | 2 | 2283726 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 8.82e-10 | 171 | 121 | 9 | chrXq26 |
| Cytoband | Xq26.3 | 9.92e-07 | 67 | 121 | 5 | Xq26.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.82e-06 | 172 | 121 | 6 | chr16p12 | |
| Cytoband | 16p11.2 | 1.24e-05 | 191 | 121 | 6 | 16p11.2 | |
| Cytoband | 16p13.11 | 3.04e-05 | 23 | 121 | 3 | 16p13.11 | |
| Cytoband | 16p12.2 | 1.30e-04 | 37 | 121 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 7.35e-04 | 404 | 121 | 6 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 8.81e-04 | 278 | 121 | 5 | chr16p11 | |
| GeneFamily | Neuroblastoma breakpoint family | 8.65e-07 | 23 | 59 | 4 | 662 | |
| GeneFamily | Ankyrin repeat domain containing | 1.35e-04 | 242 | 59 | 6 | 403 | |
| GeneFamily | PDZ domain containing | 1.37e-04 | 152 | 59 | 5 | 1220 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.24e-03 | 26 | 59 | 2 | 904 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 4.02e-03 | 29 | 59 | 2 | 396 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 2.52e-11 | 69 | 118 | 9 | M45681 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5 | 1.07e-09 | 104 | 118 | 9 | M45682 |
| Coexpression | JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN | NPIPB15 NPIPB12 TSC22D3 NPIPB11 WHAMM NPIPB3 NPIPB13 ANKRD11 CDK5RAP2 | 9.47e-06 | 302 | 118 | 9 | M38975 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.83e-09 | 193 | 120 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.35e-07 | 157 | 120 | 7 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.04e-07 | 170 | 120 | 7 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.80e-06 | 135 | 120 | 6 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-06 | 138 | 120 | 6 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.73e-06 | 145 | 120 | 6 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.86e-06 | 178 | 120 | 6 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 186 | 120 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 120 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 188 | 120 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 188 | 120 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.25e-05 | 189 | 120 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 190 | 120 | 6 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 190 | 120 | 6 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 193 | 120 | 6 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 194 | 120 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.49e-05 | 195 | 120 | 6 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-05 | 196 | 120 | 6 | 006d783a530aa6e1e6545dcc2e6b00bb300fe070 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-05 | 199 | 120 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.72e-05 | 200 | 120 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.30e-05 | 155 | 120 | 5 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.11e-05 | 159 | 120 | 5 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.32e-05 | 160 | 120 | 5 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 164 | 120 | 5 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-05 | 166 | 120 | 5 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-05 | 166 | 120 | 5 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.22e-05 | 168 | 120 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.09e-04 | 174 | 120 | 5 | e8d2aa9505817aac3fe068080774d19458f07b01 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 174 | 120 | 5 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 179 | 120 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.34e-04 | 182 | 120 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 183 | 120 | 5 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 1.38e-04 | 183 | 120 | 5 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.38e-04 | 183 | 120 | 5 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 184 | 120 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 184 | 120 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 1.41e-04 | 184 | 120 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.41e-04 | 184 | 120 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 184 | 120 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.45e-04 | 185 | 120 | 5 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.45e-04 | 185 | 120 | 5 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.52e-04 | 187 | 120 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.56e-04 | 188 | 120 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 188 | 120 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-04 | 189 | 120 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.60e-04 | 189 | 120 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.60e-04 | 189 | 120 | 5 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.64e-04 | 190 | 120 | 5 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.64e-04 | 190 | 120 | 5 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 190 | 120 | 5 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 190 | 120 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.64e-04 | 190 | 120 | 5 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.64e-04 | 190 | 120 | 5 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 191 | 120 | 5 | e5c41c3054ead03597c136eaccaf9822e6bb9d1a | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 191 | 120 | 5 | 7e24175c7fabe5ea0b22b73173da4c3a666e5eb8 | |
| ToppCell | Control-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.68e-04 | 191 | 120 | 5 | 3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 1.72e-04 | 192 | 120 | 5 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-04 | 192 | 120 | 5 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.72e-04 | 192 | 120 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-04 | 192 | 120 | 5 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.76e-04 | 193 | 120 | 5 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 1.76e-04 | 193 | 120 | 5 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.76e-04 | 193 | 120 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.76e-04 | 193 | 120 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.76e-04 | 193 | 120 | 5 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.81e-04 | 194 | 120 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.81e-04 | 194 | 120 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 194 | 120 | 5 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 196 | 120 | 5 | 624f700daea48d9bad4cc554f4776bd809ae1e54 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-04 | 197 | 120 | 5 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-04 | 197 | 120 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-04 | 197 | 120 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-04 | 198 | 120 | 5 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-04 | 198 | 120 | 5 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-04 | 199 | 120 | 5 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.03e-04 | 199 | 120 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-CD8+_Tcm|ICU-SEP / Disease, condition lineage and cell class | 2.03e-04 | 199 | 120 | 5 | d0b45c8f914b719f79a2b80b0c0dfb5caf2a3a38 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 2.03e-04 | 199 | 120 | 5 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-04 | 199 | 120 | 5 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 120 | 5 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 120 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 2.08e-04 | 200 | 120 | 5 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 2558_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.27e-06 | 197 | 107 | 8 | 7201_DN | |
| Disease | persistent Staphylococcus aureus carrier status | 1.69e-04 | 6 | 100 | 2 | EFO_0007757 | |
| Disease | Malignant neoplasm of breast | NCOA2 RAP1GAP ANK2 PPM1D TACC2 SHROOM2 CCNE1 KMT2D OTOGL ARHGAP29 OXSM HDLBP | 2.81e-04 | 1074 | 100 | 12 | C0006142 |
| Disease | Neurodevelopmental Disorders | 2.88e-04 | 93 | 100 | 4 | C1535926 | |
| Disease | leukodystrophy (implicated_via_orthology) | 4.03e-04 | 9 | 100 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | Cleft palate with cleft lip | 4.03e-04 | 9 | 100 | 2 | C0158646 | |
| Disease | Ischemic stroke | 8.40e-04 | 324 | 100 | 6 | HP_0002140 | |
| Disease | total blood protein measurement | 8.56e-04 | 449 | 100 | 7 | EFO_0004536 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 1.01e-03 | 14 | 100 | 2 | EFO_0004736, GO_0031427 | |
| Disease | Graves' disease (is_marker_for) | 1.16e-03 | 15 | 100 | 2 | DOID:12361 (is_marker_for) | |
| Disease | Autosomal recessive primary microcephaly | 1.16e-03 | 15 | 100 | 2 | cv:C3711387 | |
| Disease | T-Cell Lymphoma | 1.32e-03 | 16 | 100 | 2 | C0079772 | |
| Disease | cognitive function measurement, self reported educational attainment | 1.34e-03 | 355 | 100 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | 1-Methylhistidine measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0021543 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.02e-03 | 670 | 100 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Lymphoma, Follicular | 2.08e-03 | 20 | 100 | 2 | C0024301 | |
| Disease | pulmonary function measurement | 2.30e-03 | 77 | 100 | 3 | EFO_0003892 | |
| Disease | alkaline phosphatase measurement | NCOA2 RALGAPA1 RAP1GAP CARMIL1 ZNF512B NYNRIN PRR14L KDF1 IL6R HDLBP | 2.35e-03 | 1015 | 100 | 10 | EFO_0004533 |
| Disease | brain measurement, neuroimaging measurement | 2.71e-03 | 550 | 100 | 7 | EFO_0004346, EFO_0004464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AETPIRSPFKESCDP | 66 | O75410 | |
| PDQLLLEPCAEPERS | 816 | Q9BWT7 | |
| AAEDKPRAQLPDCAP | 461 | P55199 | |
| TEEPEKTLRANPELC | 331 | Q9NXR5 | |
| CPKAPQQEELPLSSD | 6 | Q6UB99 | |
| TEPPGDDKPRESACL | 1326 | Q6UB99 | |
| ICAEKPADPVDLSPR | 161 | Q68CJ9 | |
| LDNPKCIDRSKPSEP | 61 | Q12959 | |
| DPLIVTPDCQEKTSP | 606 | Q96GX5 | |
| ALELEEAPEPSCRCP | 46 | P0DPF6 | |
| PCSLIPTPDKEDDDR | 71 | P24864 | |
| DPETVFKRPRECDSP | 11 | P0DMU8 | |
| CLLTPENVPSDSPKE | 2386 | Q96DT5 | |
| NLCDAPDSPRPVKAS | 426 | Q9UKA4 | |
| DSSSEIPRLICDPDP | 201 | Q05D60 | |
| DPETVFKRPRECDSP | 11 | P0DMV0 | |
| PDDLASLPSCKENPE | 1056 | Q96SN8 | |
| SLPSCKENPEDVLSP | 1061 | Q96SN8 | |
| PSADDNLKTPPECVL | 276 | Q92617 | |
| ADDNLKTPPECLLTP | 316 | Q92617 | |
| PDSQPPSSKRLCLEE | 26 | Q09MP3 | |
| NPESPADTCIPKLNE | 541 | P26045 | |
| ADDNLKTPPECLLTP | 301 | Q9UND3 | |
| PSADDNLKTPPECVL | 276 | F8W0I5 | |
| ADDNLKTPPECLLTP | 316 | F8W0I5 | |
| EPSPLKESPCRDSLE | 2456 | Q01484 | |
| KLPPTLNLDCSEPEF | 406 | Q9NWU1 | |
| DPENKDPRPLFCISD | 761 | Q9C0D6 | |
| KAADCISEPVNREPP | 41 | P43304 | |
| PCRAPLQELSPAEEE | 301 | Q86XE5 | |
| ESGTLEAPERKQPPC | 61 | A6NH11 | |
| PPPDACPEKRVDDFS | 1616 | Q9BY89 | |
| PECPEIPQSERIDCT | 41 | Q2M2H8 | |
| SDPRDCPRDLPKNAA | 191 | Q10469 | |
| DPETVFKRPRECDSP | 11 | P0DMU9 | |
| ADLDKPEPTCGRSPL | 231 | Q15653 | |
| DPETVFKRPRECDSP | 11 | Q8NHU0 | |
| SPLPPSVDDNLKECL | 311 | E9PQR5 | |
| IPPLNRKADCPENAT | 286 | Q9H9L3 | |
| PSADDNLKTPPECVL | 276 | A8MRT5 | |
| ADDNLKTPPECLLTP | 316 | A8MRT5 | |
| RPSCSEDPEEKPQCF | 16 | Q99689 | |
| IPSKDPEPLEENCAK | 466 | O15297 | |
| LTPLPPSVDDNIKEC | 271 | O75200 | |
| DDNLKECLFVPLPPS | 321 | O75200 | |
| ADDNLKTPPECLLTP | 301 | F8WFD2 | |
| PEKRPCEDLRCPETT | 91 | Q96FE7 | |
| PSADDNLKTPPECVL | 276 | C9JG80 | |
| ADDNLKTPPECLLTP | 316 | C9JG80 | |
| DDNLKDCLFVPLPPS | 316 | A6NHN6 | |
| EDSECLKEPRQPNPD | 791 | Q9Y5I0 | |
| PSADDNLKTPPECLL | 276 | E5RHQ5 | |
| CFPKPLLSPEERDIE | 906 | Q52LW3 | |
| RFPDLSCEILDKPPD | 1416 | Q9P2N4 | |
| DPETVFKRPRECDSP | 11 | Q5HYN5 | |
| PERADAKDPASLPQC | 361 | Q9P0U4 | |
| DPETVFKRPRECDSP | 11 | P0DMV2 | |
| PNEIREDDLPPKCSS | 281 | Q5DX21 | |
| DVPPEEPQLSCFRKS | 111 | P08887 | |
| QVTDCKSPEDSRPPK | 41 | Q9HCG7 | |
| SRPPKETDCCNPEDS | 51 | Q9HCG7 | |
| ICRFTASPPKPQDAD | 1866 | Q8TD84 | |
| LGPDTRPPECVDQKF | 156 | Q8NCL4 | |
| DLSLEDPTACPPGRK | 1871 | Q9P0X4 | |
| DPETVFKRPRECDSP | 11 | Q5DJT8 | |
| SCKEDVLDPETSLPP | 126 | Q68D51 | |
| ANPFPKERALPCDSA | 221 | P41182 | |
| DPETVFKRPRECDSP | 11 | P0DMV1 | |
| PSRTCKDPIEDINSP | 871 | O75899 | |
| SPPVDCPRKDTKAAE | 1101 | Q5VZK9 | |
| AKIYQLDDPSCPRPE | 86 | Q2VIR3 | |
| SPLPPSVDDNLKECL | 311 | E9PJ23 | |
| CKERNLQDPVPKESP | 2626 | Q02224 | |
| DPETVFKRPRECDSP | 11 | P0DMU7 | |
| LTPLPPSVDDNIKEC | 286 | F8W1W9 | |
| DDNLKECLFVPLPPS | 336 | F8W1W9 | |
| EDFSQSKPPRVPCQD | 66 | Q6J272 | |
| PDDTKCVLTPSDFPN | 291 | Q3ZCN5 | |
| PPANRCLETIFEEPK | 2056 | Q5THK1 | |
| PSADDNLKTPPECVL | 276 | A6NJU9 | |
| ADDNLKTPPECLLTP | 316 | A6NJU9 | |
| EAALQNCPRPEISPK | 441 | Q9P2P1 | |
| LCKRSDEIPATEPPQ | 1211 | P22897 | |
| PSADDNLKTPPECLL | 276 | E9PJI5 | |
| PSADDNLKTPPECLL | 276 | P0DM63 | |
| LEKFQSCLSPEEPAP | 106 | Q99576 | |
| KEGEEDQNPPCPRLS | 1826 | Q6P3W6 | |
| KEGEEDQNPPCPRLS | 3046 | Q6P3W6 | |
| KEGEEDQNPPCPRLS | 1121 | Q5TAG4 | |
| KEGEEDQNPPCPRLS | 1311 | A0A087WUL8 | |
| KEGEEDQNPPCPRLS | 2531 | A0A087WUL8 | |
| KEGEEDQNPPCPRLS | 1211 | P0DPF2 | |
| KEGEEDQNPPCPRLS | 2431 | P0DPF2 | |
| KEGEEDQNPPCPRLS | 3651 | P0DPF2 | |
| KEGEEDQNPPCPRLS | 4871 | P0DPF2 | |
| NPTKSLQEEEPCPRF | 571 | Q9UL63 | |
| PSADDNLKTPPECLL | 276 | E9PKD4 | |
| PPSADDNLKTPPECV | 321 | E9PKD4 | |
| DEQRCSFPPPLKTEE | 11 | P47736 | |
| PEKESRQSLACPAEP | 1221 | Q13796 | |
| PLKPAYERSCDELSP | 1811 | Q9HCD6 | |
| KDDQPRPLVCESPAE | 681 | Q8TF30 | |
| LCDKPLSQDPQDRGP | 876 | Q15477 | |
| RPTELCLETYDKPPQ | 21 | Q8NAX2 | |
| AEIRCPDKDPSDTVP | 366 | Q6P1J6 | |
| RKPDPPKDENERSTC | 236 | Q96QB1 | |
| ANEPPVAPDESCLKS | 561 | O75969 | |
| EDPLQPSCRKPDAEV | 5156 | Q8IVF2 | |
| SPPPEAASEKLESCE | 731 | P51788 | |
| ECPDQLGPSPKRNTE | 21 | Q15596 | |
| VPPDENCPLKEASSR | 526 | O94762 | |
| EEANAVPLCRAKPSP | 16 | Q96A04 | |
| SPDPEPDCDILAVKT | 546 | Q7Z392 | |
| EEPPKASPESEACSL | 2011 | Q9C0A1 | |
| EKPEEPPTSNECLED | 1636 | Q6GYQ0 | |
| APSQSESEPEKAPLC | 1281 | O75970 | |
| AAADPLQKDTCPDPL | 11 | Q8NER1 | |
| DFPCDSPEKSLTLNP | 391 | Q9NX95 | |
| DCSALDRDPDLQPPS | 266 | O15370 | |
| SLPDRNDAAKDCPPD | 726 | Q8IX01 | |
| SKRPGEEVPCEPTLE | 301 | A8MPS7 | |
| RCSPLEPDFVPDEKK | 851 | Q5JSZ5 | |
| TPAEFAKLNECPLDP | 151 | Q9NW08 | |
| CLVSPEVTEPRKDPQ | 71 | O95359 | |
| PKANSRPDCDKPRAE | 676 | Q9Y4R7 | |
| ECPDPPKTDLSRESI | 736 | Q8TEA7 | |
| PSADDNLKTPPECLL | 291 | A6NJ64 | |
| TDSCSDIPLEDPDRP | 246 | Q9HB20 | |
| AADSLDTCPIPPKQA | 346 | Q96KM6 | |
| DLCPESKPEIQLSPS | 101 | P10072 | |
| ANCEPPSEKALLSEP | 141 | O15482 | |
| PLPEKAACLESAQEP | 46 | Q00341 | |
| QSSPPKEATQRPCED | 261 | Q5QJ38 | |
| DPQLKPEERESCNPQ | 951 | Q6ZMP0 | |
| ENPSPKDLFVPACLE | 1096 | P01266 | |
| QPTCKEIPDLPEEPS | 171 | O00124 | |
| SLSEDPCPSQKALDP | 446 | Q2M3C6 | |
| PKAQSDKCVPDRDPR | 306 | Q9P2T0 | |
| EKVSEPECPALEPSA | 1076 | O14686 | |
| VQEKPEPVPLESRSC | 296 | Q96BF6 |